Thursday, November 21, 2024
Home Tags APHEX

Tag: APHEX

Superbug News - CoronaVirus Watch List

Aphex BioCleanse (SNST) Making Serious Headlines.

Editor / Curator -
Aphex Biocleanse Systems
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Further Expands Distribution Channels.

Editor / Curator -
Dermaphex
Superbug News - CoronaVirus Watch List

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Editor / Curator -
Biotech News

Make Hay While the Sun Shines. Up 6,400%.

Editor / Curator -
Aphex
CoronaVirus

Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
Aphex BioCleanse
Biotech News

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Photos: Aphex BioCleanse Systems.

Editor / Curator -
APHX, APHEX
Biotech News

Aphex BioCleanse Systems Inc, Expands Sanitizer Production at its New Manufacturing...

Editor / Curator -
12Page 1 of 2

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.